Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 4, 2003, Pages 1085-1092

  Cramer, Daniel W ^a   Hornstein, Mark D ^a   McShane, Patricia ^b   Powers, R Douglas ^c   Lescault, Pamela J ^a   Vitonis, Allison F ^a   De Vivo, Immaculata ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON IVF   (United States)

^c Deaconess Waltham Hospital   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

Implantation; In vitro fertilization; Progesterone receptor

Indexed keywords

CHORIONIC GONADOTROPIN; DNA; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE RECEPTOR; RESTRICTION ENDONUCLEASE;

ADULT; ARTICLE; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GENE AMPLIFICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NIDATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT FAILURE;

EID: 0242425741     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00517-9     Document Type: Article

References (23)

1. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A, and B. EMBO J 1990;9:1603-14.
2. Conneely O, Maxwell B, Toft D, Schrader W, O'Malley B. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem Biophys Res Commun 1987;149:493-501.
3. Conneely O, Kettelberger D, Tsai M-J, Schrader W, O'Malley B. The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J Biol Chem 1989;264:14062-4.
4. Wen D, You-Feng X, Mais D, Goldman M, McDonnell D. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 1994; 14:8356-64.
5. Sartorius C, Melville M, Hovland A, Tung L, Takimoto G, Horwitz K. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 1994;8:1347-60.
6. Giangrande P, Kimbrel E, Edwards D, McDonnell D. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 2000;20:3102-15.
7. Lydon J, DeMayo F, Funk C, Mani S, Hughes A, Montgomery C Jr, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995;9:2266-78.
8. De Vivo I, Huggins G, Hankinson S, Lescault P, Boezen M, Colditz G, et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA 2002;99:12263-8.
9. Rowe S, Coughlan S, McKenna N, Garrett E, Kieback D, Carney D, et al. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res 1995;55:2743-5.
10. Fuqua S, Hill S, Chamness G, Benedix M, Greene G, O'Malley B, et al. Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors. J Natl Cancer Inst 1991;83:1157-60.
11. Lancaster J, Berchuck A, Carney M, Wiseman R, Taylor J. Progesterone receptor gene polymorphism and risk for breast and ovarian cancer [letter]. Br J Cancer 1998;78:277.
12. Manolitsas T, Englefield P, Eccles D, Campbell I. No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. Br J Cancer 1997;75:1398-9.
13. McKenna N, Kieback D, Carney D, Fanning M, McLinden J, Headon D. A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. Br J Cancer 1995;71:451-5.
14. Garrett E, Rowe S, Coughlan S, Horan R, McLinden J, Carney D, et al. Mendelian inheritance of a taqi restriction fragment length polymorphism due to an insertion in the human progesterone receptor gene and its allelic imbalance in breast cancer. Cancer Res Ther Control 1995;4:217-22.
15. Wang-Gohrke S, Chang-Claude J, Becher H, Kieback D, Runnebaum I. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res 2000;60:2348-50.
16. Spurdle A, Hopper J, Chen X, McCredie M, Giles G, Venter D, et al. The progesterone receptor exon 4 val660leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev 2002;11:439-43.
17. Cramer DW, Liberman RF, Powers DR, Hornstein MD, McShane PM, Barbieri RL. Recent trends in assisted reproductive techniques and associated outcomes. Obstet Gynecol 2000;95:61-6.
18. Snedecor GW, Cochran WG. Statistical methods. 6th ed., Ames (IA): The Iowa State University Press; 1967.
19. Kurz C, Tempfer CB, Boecskoer S, Unfried G, Nagele F, Hefler LA. The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage. J Soc Gynecol Invest 2001;8:295-8.
20. Tung L, Shen T. Mapping the unique activation function 3 in the progesterone B-receptor upstream segment: two LXXLL motifs and a tryptophan residue are required for activity. J Biol Chem 2001;276:39843-51.
21. Liu Z, Wong J. Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin. Proc Natl Acad Sci USA 2001;98:12426-31.
22. Vegeto E, Shahbaz M, Wen D, Goldman M, O'Malley B, McDonnell D. Human progesterone receptor A form is a cell-and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 1993;7:1244-55.
23. Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP, O'Malley BW. Reproductive functions of progesterone receptors. Recent Prog Horm Res 2002;57:339-55.